New, personalized medicines are coming to the market during the coming years and thus pharmaceutical companies have a need to understand how they can optimize market access and treatment pathways.
Nordic level patient journey mapping reveals the pain points and disease burden to quality of life (QoL). Through the use of qualitative and quantitative research methods, we help clients gain a holistic understanding of patient and caregiver actions, behaviours, interactions, decision-making processes, expectations, disease burden, unmet service and support needs, and challenges across the patient journey.
Insights are co-analysed by a cross-functional team, and possible service and solution ideas are developed together with healthcare professionals and patient organizations.
The insights from patient journey mapping will ensure that pharma companies provide real value for patients and their families, as well as for the healthcare professionals that participate in patient care along the entire treatment pathway.
Insights about QoL and disease burden give pharma a great possibility – together with KOL’s disease and indication-specific patient report outcome measures (PROM) – to develop and pilot the PROM findings with the clinics already engaged in the patient journey mapping phase.
Patient journey mapping (PJM) is a great tool to build relationships with healthcare professionals, patient organizations, hospitals, and decision-makers. PJM insights can be used in tactical planning, solution creation, omnichannel marketing, and creating public awareness.